Insider Transactions in Q4 2023 at Resmed Inc (RSMDF)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 27
2023
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-3.13%
|
$456,000
$152.62 P/Share
|
|
Nov 22
2023
|
Michael J Rider Global General Counsel |
SELL
Bona fide gift
|
Direct |
72
-1.03%
|
-
|
|
Nov 20
2023
|
Robert Andrew Douglas Special Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
1,375
-9.03%
|
$203,500
$148.94 P/Share
|
|
Nov 20
2023
|
Kaushik Ghoshal Chief Commercial Officer, SaaS |
SELL
Payment of exercise price or tax liability
|
Direct |
366
-2.76%
|
$54,168
$148.94 P/Share
|
|
Nov 20
2023
|
Michael J. Farrell Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,352
-0.53%
|
$348,096
$148.94 P/Share
|
|
Nov 16
2023
|
Jan De Witte Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,768
+18.33%
|
-
|
|
Nov 16
2023
|
Richard Sulpizio Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,768
+9.57%
|
-
|
|
Nov 16
2023
|
Harjit Gill Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,768
+16.49%
|
-
|
|
Nov 16
2023
|
John Hernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
884
+22.98%
|
-
|
|
Nov 16
2023
|
Carol Burt Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,768
+31.49%
|
-
|
|
Nov 16
2023
|
Peter C Farrell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,768
+0.97%
|
-
|
|
Nov 16
2023
|
Desney Tan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,768
+31.49%
|
-
|
|
Nov 16
2023
|
Ronald R Taylor Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,768
+7.25%
|
-
|
|
Nov 16
2023
|
Karen Drexler Director |
BUY
Grant, award, or other acquisition
|
Direct |
884
+9.06%
|
-
|
|
Nov 15
2023
|
Michael J. Farrell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,678
-1.27%
|
$863,056
$152.04 P/Share
|
|
Nov 15
2023
|
Michael J. Farrell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,678
+1.26%
|
$323,646
$57.76 P/Share
|
|
Nov 13
2023
|
Michael J Rider Global General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
437
-1.51%
|
$62,491
$143.6 P/Share
|
|
Nov 13
2023
|
Kaushik Ghoshal Chief Commercial Officer, SaaS |
SELL
Payment of exercise price or tax liability
|
Direct |
1,025
-3.65%
|
$146,575
$143.6 P/Share
|
|
Nov 13
2023
|
Robert Andrew Douglas Special Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
1,703
-5.16%
|
$243,529
$143.6 P/Share
|
|
Nov 13
2023
|
Michael J. Farrell Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,450
-0.63%
|
$1,208,350
$143.6 P/Share
|
|
Nov 13
2023
|
Lucile Blaise President, Sleep & RC Business |
SELL
Payment of exercise price or tax liability
|
Direct |
135
-1.29%
|
$19,305
$143.6 P/Share
|
|
Nov 13
2023
|
Peter C Farrell Director |
SELL
Payment of exercise price or tax liability
|
Direct |
325
-0.18%
|
$46,475
$143.6 P/Share
|
|
Nov 13
2023
|
Harjit Gill Director |
SELL
Payment of exercise price or tax liability
|
Direct |
79
-1.09%
|
$11,297
$143.6 P/Share
|
|
Nov 01
2023
|
Michael J Rider Global General Counsel |
SELL
Open market or private sale
|
Direct |
25
-0.34%
|
$3,575
$143.42 P/Share
|
|
Oct 16
2023
|
Michael J. Farrell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,675
-1.25%
|
$794,500
$140.7 P/Share
|
|
Oct 16
2023
|
Michael J. Farrell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,675
+1.23%
|
$323,475
$57.76 P/Share
|
|
Oct 02
2023
|
Michael J Rider Global General Counsel |
SELL
Open market or private sale
|
Direct |
25
-0.34%
|
$3,625
$145.92 P/Share
|